Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Each small step forward reduces the risk of my CTIX investment.

The news today of Prurisol proceeding to a stage 2b FDA trial instead of a stage 3 trial on the surface is disappointing.

The reality is the success of the previous trial with moderate psoriasis allows CTIX to attempt to expand the indications for Prurisol to include severe psoriasis. If the 2b trial is successful Prurisol will be a more valuable pharmaceutical.

The 2b trial should be short. Hopefully CTIX's new President will focus on pushing Prurisol forward to approval.

Ctix's 1000% trial success rate in FDA trials should give share holders reassurance as our drugs move through the trials.

When I first invested in CTIX my thought was we only needed to have 1 drug approved for my investment to be successful. While I still believe that is true, we now have multiple promising drugs each with multiple possible indications progressing through the trials.CTIX's success in the clinical trials has significantly reduced the risk of our investment.

GLTA farrell